Artykuły w czasopismach na temat „Cancer tumer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cancer tumer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Battah, Arwa, Iyad Farouji, Theodore DaCosta, et al. "S2447 Tumer Lysis Syndrome - A Rare Complication of Gastric Cancer After Initiation of Keytruda." American Journal of Gastroenterology 118, no. 10S (2023): S1716. http://dx.doi.org/10.14309/01.ajg.0000959428.89405.12.
Pełny tekst źródłaBlaich, Günter, Hella Raade, and Manfred Metzler. "Modification of 7,8–benzoflavone metabolism in hamster liver and kidney microsomes by hepatic tumer inducing treatments." Carcinogenesis 11, no. 1 (1990): 95–101. http://dx.doi.org/10.1093/carcin/11.1.95.
Pełny tekst źródłaParsons, Heather A., Timothy Blewett, Xiangying Chu, et al. "Abstract PD11-06: PD11-06 Circulating tumor DNA association with residual cancer burden after neoadjuvant therapy in triple negative breast cancer in TBCRC 030." Cancer Research 83, no. 5_Supplement (2023): PD11–06—PD11–06. http://dx.doi.org/10.1158/1538-7445.sabcs22-pd11-06.
Pełny tekst źródłaCurran, Paytin, DeLaney Anderson, Jeffrey Okojie, et al. "Abstract 5034: Comparative whole genome sequencing between matched cryopreserved and FFPE tumor samples." Cancer Research 85, no. 8_Supplement_1 (2025): 5034. https://doi.org/10.1158/1538-7445.am2025-5034.
Pełny tekst źródłaCho, Bong Jun, Hans H. Kim, David J. Lee, et al. "MicroRNA-21 inhibitor potentiates anti-tumor effect of radiation therapy in vitro and in vivo." Tumor Microenvironment and Therapy 2, no. 1 (2014): 1–13. http://dx.doi.org/10.2478/tumor-2014-0001.
Pełny tekst źródłaLavekar, G. S. "Arbud-Tumor-Cancer- a concise integrative review." Journal of Clinical Oncology Reports 1, no. 1 (2023): 01–05. http://dx.doi.org/10.58489/2836-5062/001.
Pełny tekst źródłaGARCÍA CEBRIÁN, MARÍA JOSÉ, MONIKA BAUDEN, ROLAND ANDERSSON, STEFAN HOLDENRIEDER, and DANIEL ANSARI. "Paradoxical Role of HMGB1 in Pancreatic Cancer: Tumor Suppressor or Tumor Promoter?" Anticancer Research 36, no. 9 (2016): 4381–90. http://dx.doi.org/10.21873/anticanres.10981.
Pełny tekst źródłaSwathi, Madhavan* T. Keerthana A. Sowmiya D. Kilimozhi. "T Cell Line Treatment for Cancer Using Tumor-Infiltrating Lymphocytes." International Journal of Pharmaceutical Sciences 2, no. 11 (2024): 1653–68. https://doi.org/10.5281/zenodo.14245431.
Pełny tekst źródłaMasood, Behzad, Afzaal Aleem Khan, Muhammad Usman, et al. "Institution Based Tumor Registry, Benazir Bhutto Hospital: A Four Year Data Based Analysis." Journal of Rawalpindi Medical College VOL 23 NO S-1 (2019): STUDENTS SUPPLEMENT, no. 23(S-1) (2019): 37–41. https://doi.org/10.5281/zenodo.5684784.
Pełny tekst źródłaShalini, Das, Jahan Nushrat, and Mal Chittabrata. "In-silico Identification of lncRNA Functionality in Cancers Related to Obesity." International Journal of BioSciences and Technology (IJBST) ISSN: 0974-3987 13, no. 3 (2020): 34–41. https://doi.org/10.5281/zenodo.4275605.
Pełny tekst źródłaSK, Deshmukh. "Immune Cells in the Tumor Microenvironment and Cancer Stem Cells: Interplay for Tumor Progression." Journal of Embryology & Stem Cell Research 2, no. 2 (2018): 1–2. http://dx.doi.org/10.23880/jes-16000109.
Pełny tekst źródłaFejzić, Hanifa. "Tumor marker CA 15-3 in breast cancer patients." Acta Medica Academica 44, no. 1 (2015): 39–46. http://dx.doi.org/10.5644/ama2006-124.125.
Pełny tekst źródłaOstojić, Marija, Ana Djurić, Kristina Živić, and Jelena Grahovac. "Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology." Plos One 19, no. 5 (2023): 0299685. https://doi.org/10.1371/journal.pone.0299685.
Pełny tekst źródłaChandana, Kamili a. *. Shafeen Begum a. Abbulu Konda a. Ravi Shankar Kakaraparthi b. Uma Maheshwararao Vattikutti c. "NANO-ANTIANGIOGENESIS IN CANCER THERAPY." Journal of Pharma Research 8, no. 5 (2019): 244–49. https://doi.org/10.5281/zenodo.2678000.
Pełny tekst źródłaTavartkiladze, Alexandre, Gaiane Simonia, Ruite Lou, et al. "Exploring AminoSineTriComplex (AminoTriComplex) for Multimodal Tumor Management in Carcinogen-Induced Rat Models: Insights from Blood Biomarker Analysis." Journal of Cancer Research 2, no. 1 (2024): 1–18. https://doi.org/10.64030/2578-3726.02.01.13.
Pełny tekst źródłaArbia, Abbes, Boudemia Rihab, and Rechreche Hocine. "BENEFITS OF METFORMIN USE BY BREAST AND COLORECTAL CANCER PATIENTS WITH TYPE 2 DIABBETES MILLITUS: A CASE-CONTROL STUDY IN JIJEL PROVINCE (ALGERIA)." Journal of Applied Biological Sciences 17, no. 2 (2023): 375–90. https://doi.org/10.5281/zenodo.8018993.
Pełny tekst źródłaDetrés Román, Carlos R., Megan M. Erwin, Michael W. Rudloff, et al. "Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control." Journal for ImmunoTherapy of Cancer 12, no. 10 (2024): e009129. http://dx.doi.org/10.1136/jitc-2024-009129.
Pełny tekst źródłaShashi, Ranjan, and Bharti Ramendra. "Correlation between Breast Cancer Grading, Staging, and Hormone Receptor Status in Rural India: A Comprehensive Study." International Journal of Pharmaceutical and Clinical Research 16, no. 5 (2024): 2907–11. https://doi.org/10.5281/zenodo.13823771.
Pełny tekst źródłaLi, Lin, Mengyuan Li, Zehang Jiang, and Xiaosheng Wang. "ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer." Cells 8, no. 7 (2019): 678. http://dx.doi.org/10.3390/cells8070678.
Pełny tekst źródłaZhang, Chunfeng, Chenyu Hu, Kunqi Su, et al. "The Integrative Analysis of Thrombospondin Family Genes in Pan-Cancer Reveals that THBS2 Facilitates Gastrointestinal Cancer Metastasis." Journal of Oncology 2021 (November 10, 2021): 1–19. http://dx.doi.org/10.1155/2021/4405491.
Pełny tekst źródłaNenciu, Adina-Elena, C. G. Nenciu, R. Fodoroiu, Florica Șandru, and M. C. Dumitrașcu. "TUMOR MARKERS IN OVARIAN CANCER." Journal of Surgical Sciences 7, no. 2 (2020): 79–84. http://dx.doi.org/10.33695/jss.v7i2.356.
Pełny tekst źródłaDa Gama Duarte, Jessica, Luke T. Quigley, Anna Rachel Young, et al. "Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies." International Journal of Molecular Sciences 22, no. 20 (2021): 11220. http://dx.doi.org/10.3390/ijms222011220.
Pełny tekst źródłaKashyap, Poonam. "Ovarian tumor: a review." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 9 (2021): 3657. http://dx.doi.org/10.18203/2320-1770.ijrcog20213510.
Pełny tekst źródłaMargul, Daniel, Camilla Yu, and Mariam M. AlHilli. "Tumor Immune Microenvironment in Gynecologic Cancers." Cancers 15, no. 15 (2023): 3849. http://dx.doi.org/10.3390/cancers15153849.
Pełny tekst źródłaDuval, Adrian, Cheryl Jeanneret, Tania Santoro, and Olivier Dormond. "mTOR and Tumor Cachexia." International Journal of Molecular Sciences 19, no. 8 (2018): 2225. http://dx.doi.org/10.3390/ijms19082225.
Pełny tekst źródłaDiao, Mingxin, Yue Li, Zihui Gao, Chunji Wang, and Yaming Gu. "Comparison of prognosis after transurethral resection of bladder tumor between solitary and multiple bladder cancers." Medicine 103, no. 44 (2024): e40314. http://dx.doi.org/10.1097/md.0000000000040314.
Pełny tekst źródłaShahriar, Mohammad Hasan, Mohammad Kamal, Tariqul Islam, Muhammad Rakibuz-Zaman, and Habibul Ahsan. "Tumor Burden in Bangladesh: A Pathology-Based Tumor Registry Overview." Journal of Global Oncology 3, no. 2_suppl (2017): 34s. http://dx.doi.org/10.1200/jgo.2017.009548.
Pełny tekst źródłaGerke, Margo B., Caroline S. Jansen, and Mehmet A. Bilen. "Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications." Cancers 16, no. 12 (2024): 2280. http://dx.doi.org/10.3390/cancers16122280.
Pełny tekst źródłaHeit, John A., Tanya M. Petterson, Randolph S. Marks, Kent R. Bailey, and L. Joseph Melton. "The Risk of Venous Thromboembolism (VTE) among Cancer Patients by Tumor Site: A Population-Based Study." Blood 104, no. 11 (2004): 2596. http://dx.doi.org/10.1182/blood.v104.11.2596.2596.
Pełny tekst źródłaAkolkar, Dadasaheb, Darshana Patil, Raymond Page, et al. "Circulating ensembles of tumor-associated cells in gastrointestinal cancers." Journal of Clinical Oncology 38, no. 4_suppl (2020): 808. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.808.
Pełny tekst źródłaKazbarienė, Birutė. "Tumor and immunity." Medicina 45, no. 2 (2009): 162. http://dx.doi.org/10.3390/medicina45020021.
Pełny tekst źródłaGupta, Brinda, Sharon Wu, Sai-Hong Ignatius Ou, et al. "NRG1 fusions in solid tumors." Journal of Clinical Oncology 41, no. 16_suppl (2023): 3132. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3132.
Pełny tekst źródłaLiou, Geou-Yarh. "Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers." Journal of Immunology Research 2017 (2017): 1–10. http://dx.doi.org/10.1155/2017/7979637.
Pełny tekst źródłaCohen, Ivan J., and Ronald Blasberg. "Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer." Breast Cancer: Basic and Clinical Research 11 (January 1, 2017): 117822341773156. http://dx.doi.org/10.1177/1178223417731565.
Pełny tekst źródłaMochimaru, Yuta, and Kiyotsugu Yoshida. "Functional Roles of DYRK2 as a Tumor Regulator." Current Issues in Molecular Biology 45, no. 10 (2023): 8539–51. http://dx.doi.org/10.3390/cimb45100538.
Pełny tekst źródłaChen, Chaoran, Yueming Ding, Huiyang Liu, Mengyao Sun, Honggang Wang, and Dongdong Wu. "Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers." International Journal of Molecular Sciences 23, no. 1 (2022): 519. http://dx.doi.org/10.3390/ijms23010519.
Pełny tekst źródłaGan, Xin, Yunqian Zeng, Jiaquan Huang, Xin Chen, Hao Kang, and Shuaiwen Huang. "Tumor-Derived Sarcopenia Factors Are Diverse in Different Tumor Types: A Pan-Cancer Analysis." Biomedicines 12, no. 2 (2024): 329. http://dx.doi.org/10.3390/biomedicines12020329.
Pełny tekst źródłaAkshay, Sonaji Bhambre, Bhimrao Giri Ashok, Ashok Mundhe Swapnil, and Bharat Mahadik Arjun. "Precision and personalized medicine: new way for cancer management." GSC Biological and Pharmaceutical Sciences 18, no. 3 (2022): 046–53. https://doi.org/10.5281/zenodo.6392529.
Pełny tekst źródłaHan, Yi-chun, David Hsieh, and Shian-Jiun (SJ) Shih. "Abstract 4003: Improved drug screening and resistance monitoring using cancer organoids derived from dissociated tumor cells and circulating tumor cells." Cancer Research 85, no. 8_Supplement_1 (2025): 4003. https://doi.org/10.1158/1538-7445.am2025-4003.
Pełny tekst źródłaWeidemann, Sören, Natalia Gorbokon, Maximilian Lennartz, et al. "Abstract 3303: High homogeneity of mesothelin expressionin primary and metastatic ovarian cancer." Cancer Research 83, no. 7_Supplement (2023): 3303. http://dx.doi.org/10.1158/1538-7445.am2023-3303.
Pełny tekst źródłaSun, Hao, Ying Zheng, Ryan Strauch, Yi Zhang, Minqi Huang, and Luke Tsai. "Abstract 1361: Severe hyperglycemia and hyperlipidemia alters tumor growth and immune profiles in syngeneic tumor models." Cancer Research 85, no. 8_Supplement_1 (2025): 1361. https://doi.org/10.1158/1538-7445.am2025-1361.
Pełny tekst źródłaSrinivasan, Ajay, Dadasaheb B. Akolkar, Pradip Fulmali, et al. "Circulating ensembles of tumor-associated cells in genitourinary cancers." Journal of Clinical Oncology 38, no. 6_suppl (2020): 718. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.718.
Pełny tekst źródłaN, Chaitra, Sundar RNS, Kumar HKS, Nataraju G, and Esaivani KB. "Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining." Journal of Medical and Scientific Research 11, no. 4 (2023): 285–89. http://dx.doi.org/10.17727/jmsr.2023/11-53.
Pełny tekst źródłaGajim, Sabina, and Ion Mereuță. "CANCER AND MAJOR METABOLIC RISKS." Deutsche internationale Zeitschrift für zeitgenössische Wissenschaft 100 (March 20, 2025): 22–24. https://doi.org/10.5281/zenodo.15061509.
Pełny tekst źródłaHampel, Heather. "Abstract IA004: Universal tumor screening for Lynch syndrome versus germline multi-gene panel testing for all endometrial cancer patients." Clinical Cancer Research 30, no. 5_Supplement (2024): IA004. http://dx.doi.org/10.1158/1557-3265.endo24-ia004.
Pełny tekst źródłaNadhan, Revathy, Srishti Kashyap, Ji Hee Ha, et al. "Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies." Metabolites 13, no. 5 (2023): 618. http://dx.doi.org/10.3390/metabo13050618.
Pełny tekst źródłaLooi, Chin-King, Ling-Wei Hii, Siew Ching Ngai, Chee-Onn Leong, and Chun-Wai Mai. "The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?" Biomedicines 8, no. 9 (2020): 334. http://dx.doi.org/10.3390/biomedicines8090334.
Pełny tekst źródłaJiramonai, Luksika, Xing-Jie Liang, and Mengliang Zhu. "Extracellular Vesicle-Based Strategies for Tumor Immunotherapy." Pharmaceutics 17, no. 2 (2025): 257. https://doi.org/10.3390/pharmaceutics17020257.
Pełny tekst źródłaDillen, Ana, Indy Bui, Megan Jung, Stephanie Agioti, Apostolos Zaravinos, and Benjamin Bonavida. "Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1." Cancers 16, no. 6 (2024): 1237. http://dx.doi.org/10.3390/cancers16061237.
Pełny tekst źródłaSHAHLA, YAZDANI, BOUZARI ZINATOSSADAT, JAMALI SAHAR, VAKILI MOHSEN, and AKRAM SADAT. "EARLY SYMPTOMS OF OVARIAN CANCER." Journal of Medicine and Health Research 2, no. 2 (2017): 59–64. https://doi.org/10.5281/zenodo.1413003.
Pełny tekst źródła